The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis

Journal of Neuroimmunology

Volumn 148, Issue 1-2, 2004, Pages 183-191

  Kakoulidou, M ^a   Ahlberg R ^a   Yi, Q ^a   Giscombe, R ^a   Pirskanen, R ^a   Lefvert, A K ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Auto antibodies; B lymphocyte; Myasthenia gravis; T lymphocyte; Twin

Indexed keywords

ANTIBODY; ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; AZATHIOPRINE; CHOLINERGIC RECEPTOR; CORTICOTROPIN; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PYRIDOSTIGMINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HEALTH STATUS; HUMAN; MONOZYGOTIC TWINS; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL; T LYMPHOCYTE; TWIN DISCORDANCE;

EID: 1242294592     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.09.019     Document Type: Article

References (52)

1. Ahlberg R., Yi Q., Pirskanen R., Matell G., Swerup C., Rieber E.P., Riethmuller G., Holm G., Lefvert A.K. Treatment of myasthenia gravis with anti-CD4 antibody: correlates to decreased T-cell autoreactivity. Neurology. 44(9):1994;1732-1737.
2. Allen N., Kissel P., Piktrasiuk D., Perlow M.J. Myasthenia gravis in monozygotic twins. Clinical follow-up nine years after thymectomy. Arch. Neurol. 41(9):1984;994-996.
3. Brix T.H., Kyvik K.O., Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab. 85(2):2000;536-539.
4. Crosti F., Armanini M., Confalonieri P., Antozzi C., Mantegazza R. Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression. J. Neurol. 241(4):1994;218-222.
5. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., Walker A., Mack T.M. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum. 35(3):1992;311-318.
6. Emery P., Gentry K.C., Mackay I.R., Muirden K.D., Rowley M. Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum. 30(8):1987;849-856.
7. Flodstrom M., Shi F.D., Sarvetnick N., Ljunggren H.G. The natural killer cell - friend or foe in autoimmune disease? Scand. J. Immunol. 55(5):2002;432-441.
8. Gruber R., Reiter C., Riethmuller G. Triple immunofluorescence flow cytometry, using whole blood, of CD4+ and CD8+ lymphocytes expressing CD45RO and CD45RA. J. Immunol. Methods. 163(2):1993;173-179.
9. Grunewald J., Wigzell H. T cell expansions in healthy individuals. Immunologist. 4:1996;99-103.
10. Grunewald J., Ahlberg R., Lefvert A.K., DerSimonian H., Wigzell H., Janson C.H. Abnormal T-cell expansion and V-gene usage in myasthenia gravis patients. Scand. J. Immunol. 34(2):1991;161-168.
11. Huang D., Pirskanen R., Hjelmstrom P., Lefvert A.K. Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis. J. Neuroimmunol. 81(1-2):1998;76-81.
12. Huang D., Liu L., Noren K., Xia S.Q., Trifunovic J., Pirskanen R., Lefvert A.K. Genetic association of Ctla-4 to myasthenia gravis with thymoma. J. Neuroimmunol. 1;88(1-2):1998;192-198.
13. Huang D.R., Pirskanen R., Matell G., Lefvert A.K. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis. J. Neuroimmunol. 1;94(1-2):1999;165-171.
14. Huang D.R., Shi F.-D., Giscombe R., Zhou Y.H., Ljunggren H.-G., Lefvert A.K. Disruption of the Il-1β gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis. Eur. J. Immunol. 31:2001;225-232.
15. Jerne N.K. Towards a network theory of the immune system. Ann. Immunol. (Paris). 125C(1-2):1974;373-389.
16. Kalb B., Matell G., Pirskanen R., Lambe M. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden. Neuroepidemiology. 21(5):2002;221-225.
17. Lefvert A.K. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis. Monogr. Allergy. 22:1987;57-70.
18. Lefvert A.K. The start of an autoimmune disease: idiotypic network during early progression of myasthenia gravis. Ann. Inst. Pasteur., Immunol. 139(6):1988;633-643.
19. Lefvert A.K., Holm G. Idiotypic network in myasthenia gravis demonstrated by human monoclonal B-cell lines. Scand. J. Immunol. 26(5):1987;573-578.
20. Lefvert A.K., Bergstrom K., Matell G., Osterman P.O., Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J. Neurol. Neurosurg. Psychiatry. 41(5):1978;394-403.
21. Lefvert A.K., Pirskanen R., Svanborg E. Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis. J. Neuroimmunol. 9(1-2):1985;41-53.
22. Lefvert A.K., Pirskanen R., Eng H., Sundewall A.C., Svanborg E. B cell and autoantibody repertoire in a pair of monozygotic twins discordant for myasthenia gravis. Clin. Immunol. Immunopathol. 53(2):1989;161-170.
23. Lennon V.A., Lindstrom J.M., Seybold M.E. Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann. N.Y. Acad. Sci. 274:1976;283-299.
24. Lindstrom J.M., Seybold M.E., Lennon V.A., Whittingham S., Duane D.D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 26(11):1976;1054-1059.
25. Loveridge J.A., Rosenberg W.M., Kirkwood T.B., Bell J.I. The genetic contribution to human T-cell receptor repertoire. Immunology. 74(2):1991;246-250.
26. MacGregor A.J., Ollier W.E., Venkovsky J., Mageed R.A., Carthy D., Silman A.J. Rheumatoid factor isotypes in monozygotic and dizygotic twins discordant for rheumatoid arthritis. J. Rheumatol. 22(12):1995;2203-2207.
27. Malhotra U., Spielman R., Concannon P. Variability in T cell receptor V beta gene usage in human peripheral blood lymphocytes. Studies of identical twins, siblings, and insulin-dependent diabetes mellitus patients. J. Immunol. 149(5):1992;1802-1808.
28. Mokhtarian F., Pino M., Ofosu-Appiah W., Grob D. Phenotypic and functional characterization of T cells from patients with myasthenia gravis. J. Clin. Invest. 86(6):1990;2099-2108.
29. Morimoto C., Hafler D.A., Weiner H.L., Letvin N.L., Hagan M., Daley J., Schlossman S.F. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N. Engl. J. Med. 316(2):1987;67-72.
30. Murphy J., Murphy S.F. Myasthenia gravis in identical twins. Neurology. 36(1):1986;78-80.
31. Mylvaganam R., Ahn Y.S., Sprinz P.G., Garcia R.O., Harrington W.J. Sex difference in the CD4+ CD45R+ T lymphocytes in normal individuals and its selective decrease in women with idiopathic thrombocytopenic purpura. Clin. Immunol. Immunopathol. 52(3):1989;473-485.
32. Namba T., Brunner N.G., Brown S.B., Muguruma M., Grob D. Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. Arch. Neurol. 25(1):1971;49-60.
33. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., Nolan N., Hegarty J., O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28(1):1998;84-90.
34. Olmos P., A'Hern R., Heaton D.A., Millward B.A., Risley D., Pyke D.A., Leslie R.D. The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia. 31(10):1988;747-750.
35. Poussin M.A., Goluszko E., David C.S., Franco J.U., Christadoss P. HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production. J. Autoimmun. 17(3):2001;175-180.
36. Reichert T., DeBruyere M., Deneys V., Totterman T., Lydyard P., Yuksel F., Chapel H., Jewell D., Van Hove L., Linden J.et al. Lymphocyte subset reference ranges in adult Caucasians. Clin. Immunol. Immunopathol. 60(2):1991;190-208.
37. Schlesinger I., Rabinowitz R., Brenner T., Abramsky O., Schlesinger M. Changes in lymphocyte subsets in myasthenia gravis: correlation with level of antibodies to acetylcholine receptor and age of patient. Neurology. 42(11):1992;2153-2157.
38. Silman A.J., MacGregor A.J., Thomson W., Holligan S., Carthy D., Farhan A., Ollier W.E. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol. 32(10):1993;903-907.
39. Stephens L.A., Mottet C., Mason D., Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31(4):2001;1247-1254.
40. Sundewall A.C., Lefvert A.K. Acetylcholine receptor antibodies in primary biliary cirrhosis: characterization of antigen and idiotypic specificity. Scand. J. Immunol. 31(4):1990;477-484.
41. Utz U., Biddison W.E., McFarland H.F., McFarlin D.E., Flerlage M., Martin R. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature. 364(6434):1993;243-247.
42. van den Beemd R., Boor P.P., van Lochem E.G., Hop W.C., Langerak A.W., Wolvers-Tettero I.L., Hooijkaas H., van Dongen J.J. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry. 40(4):2000;336-345.
43. Verge C.F., Gianani R., Yu L., Pietropaolo M., Smith T., Jackson R.A., Soeldner J.S., Eisenbarth G.S. Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes [see comments]. Diabetes. 44(10):1995;1176-1179.
44. Victor K.D., Pascual V., Lefvert A.K., Capra J.D. Human anti-acetylcholine receptor antibodies use variable gene segments analogous to those used in autoantibodies of various specificities. Mol. Immunol. 29(12):1992;1501-1506.
45. Vuillier F., Scott-Algara D., Dighiero G. Extensive analysis of lymphocyte subsets in normal subjects by three-color immunofluorescence. Nouv. Rev. Fr. Hematol. 33(1):1991;31-38.
46. Wang X.B., Kakoulidou M., Qiu Q., Giscombe R., Huang D., Pirskanen R., Lefvert A.K. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis. Genes Immun. 3(1):2002;46-49.
47. Worthington J., Silman A.J. Genetic control of autoimmunity, lessons from twin studies. Clin. Exp. Immunol. 101(3):1995;390-392.
48. Yi Q., Lefvert A.K. Idiotypic and antiidiotypic T and B lymphocytes in myasthenia gravis. J. Immunol. 149(10):1992;3423-3426.
49. Yi Q., Lefvert A.K. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes. J. Immunol. 153(7):1994;3353-3359.
50. Yi Q., Ahlberg R., Lefvert A.K. T cells with specificity for idiotypic determinants on human monoclonal autoantibodies in myasthenia gravis. Res. Immunol. 143(2):1992;149-156.
51. Yi Q., Pirskanen R., Lefvert A.K. Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravis. J. Neuroimmunol. 42(2):1993;215-222.
52. Yi Q., Ahlberg R., Pirskanen R., Lefvert A.K. Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J. Neuroimmunol. 50(2):1994;177-186.